FindTrial
Sign In

Clinical validation of T cell related molecules

Clinical validation of T cell related molecules

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049980
Enrollment
Unknown
Registered
2021-08-15
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumour

Interventions

Group one:None

Sponsors

Huzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed by pathology; 2.The self or his agent is signing the informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with other malignant tumors; 2.The patient has severe heart and lung disease;

Design outcomes

Primary

MeasureTime frame
T-cell related genes ;T-cell related protein;—

Countries

China

Contacts

Public ContactHan Shuwen

Huzhou Central Hospital

shuwenhan985@163.com+86 18768233016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026